Last reviewed · How we verify

Gelsemium Sempervirens — Competitive Intelligence Brief

Gelsemium Sempervirens (Gelsemium Sempervirens) competitive landscape: 1 comparator, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Homeopathic remedy. Area: Psychiatry / Neurology.

marketed Homeopathic remedy Psychiatry / Neurology Small molecule Live · refreshed every 30 min

Target snapshot

Gelsemium Sempervirens (Gelsemium Sempervirens) — University Hospital, Grenoble. Gelsemium sempervirens is a homeopathic preparation derived from the yellow jasmine plant that is traditionally used to modulate anxiety and nervous system function.

Comparator set (1 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Gelsemium Sempervirens TARGET Gelsemium Sempervirens University Hospital, Grenoble marketed Homeopathic remedy
Traumeel S inj Traumeel S inj Biologische Heilmittel Heel GmbH phase 3 Homeopathic remedy

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Homeopathic remedy class)

  1. Biologische Heilmittel Heel GmbH · 1 drug in this class
  2. University Hospital, Grenoble · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Gelsemium Sempervirens — Competitive Intelligence Brief. https://druglandscape.com/ci/gelsemium-sempervirens. Accessed 2026-05-14.

Build your own brief

Pick any drug + add comparators: